Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CROWN-1: High-dose vs Low-dose Rosuvastatin in ACS
NCT03007524Phase 4Unknown
- Sponsor
- Nanjing First Hospital
- Start
- Jul 2016
- Primary completion
- Dec 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of rosuvastatin in acute coronary syndrome (ACS), sponsored by Nanjing First Hospital. Status: unknown.
02
Drugs
rosuvastatin
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT03007524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03007524.